保守性液体管理与主动去复苏在重症患者中的可行性:RADAR-2随机临床试验
RADAR-2为开放标签、平行组、分配隐藏的随机临床可行性试验,纳入ICU内机械通气成人180例,入组时间为入住ICU后24至48小时,随机分为两阶段液体策略组(保守液体管理,若存在液体过负荷则主动去复苏)与常规治疗组。主要终点为研究第3天开始前24小时液体平衡,干预组为-840±1746 mL,低于常规治疗组的+130±1401 mL(P<0.01);第3天和第5天累积液体平衡在干预组更低。临床结局无显著差异,30天死亡率干预组19/90(21.6%)vs 常规治疗组14/89(15.6%),P=0.32。作者认为该策略可行,可能带来获益或伤害,鉴于当代临床实践差异大,需大样本充分把握度试验验证。
要点
- 在ICU机械通气成人中,保守液体管理联合主动去复苏使研究第3天前24小时液体平衡达-840±1746 mL,低于常规治疗的+130±1401 mL(P<0.01)。
- 干预组第3天和第5天累积液体平衡均低于常规治疗组。
- 30天死亡率干预组19/90(21.6%)vs 常规治疗组14/89(15.6%),P=0.32,无显著差异。
- 作者指出组间基线不平衡和统计把握度不足限制了对临床结局的解释。
- 作者认为该策略可行,可能带来获益或伤害,需大样本充分把握度试验验证临床有效性。
适用人群与场景
- 机械通气成人患者,预计需重症监护超过下一个日历日,于入住ICU后24至48小时入组。
处置流程与药物剂量
- 干预组采用两阶段液体策略:保守液体管理,若存在液体过负荷则主动去复苏(使用利尿剂或超滤主动清除蓄积液体)。
- 对照组接受常规治疗。
研究设计与关键结果
- 开放标签、平行组、分配隐藏的随机临床可行性试验,180例患者随机,1例退出后干预组89例与常规治疗组90例进行比较。
- 主要终点:研究第3天开始前24小时液体平衡,干预组-840±1746 mL vs 常规治疗组+130±1401 mL,P<0.01。
- 次要终点:累积液体平衡在第3天和第5天干预组更低;30天死亡率干预组19/90(21.6%)vs 常规治疗组14/89(15.6%),P=0.32;机械通气时间等临床结局两组无显著差异。
- 作者指出组间基线不平衡和统计把握度不足限制了对临床结局的解释。
证据类型、等级与局限
- 证据类型:开放标签、平行组、分配隐藏的随机临床可行性试验。
- 局限:组间基线不平衡和统计把握度不足限制了对临床结局的解释;作者认为需大样本充分把握度试验验证。
对床旁实践的改变
- 作者认为保守液体管理联合主动去复苏策略可行,可降低液体平衡,但可能带来获益或伤害。
- 作者认为鉴于当代临床实践差异大,需大样本充分把握度试验研究保守液体策略在重症患者中的临床有效性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Fluid overload is common in critical illness and is associated with mortality. This study investigated the feasibility of a randomised trial comparing conservative fluid administration and deresuscitation (active removal of accumulated fluid using diuretics or ultrafiltration) with usual care in critical illness.
METHODS: Open-label, parallel-group, allocation-concealed randomised clinical feasibility trial. Mechanically ventilated adult patients expected to require critical care beyond the next calendar day were enrolled between 24 and 48 h following admission to the intensive care unit (ICU). Patients were randomised to either a 2-stage fluid strategy comprising conservative fluid administration and, if fluid overload was present, active deresuscitation, or usual care. The primary endpoint was fluid balance in the 24 h up to the start of study day 3. Secondary endpoints included cumulative fluid balance, mortality, and duration of mechanical ventilation.
RESULTS: One hundred and eighty patients were randomised. After withdrawal of 1 patient, 89 patients assigned to the intervention were compared with 90 patients assigned to the usual care group. The mean plus standard deviation (SD) 24-h fluid balance up to study day 3 was lower in the intervention group (- 840 ± 1746 mL) than the usual care group (+ 130 ± 1401 mL; P < 0.01). Cumulative fluid balance was lower in the intervention group at days 3 and 5. Overall, clinical outcomes did not differ significantly between the two groups, although the point estimate for 30-day mortality favoured the usual care group [intervention arm: 19 of 90 (21.6%) versus usual care: 14 of 89 (15.6%), P = 0.32]. Baseline imbalances between groups and lack of statistical power limit interpretation of clinical outcomes.
CONCLUSIONS: A strategy of conservative fluid administration and active deresuscitation is feasible, reduces fluid balance compared with usual care, and may cause benefit or harm. In view of wide variations in contemporary clinical practice, large, adequately powered trials investigating the clinical effectiveness of conservative fluid strategies in critically ill patients are warranted.
参考来源
- Silversides JA, McMullan R, Emerson LM, et al. Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial. Intensive Care Med. 2021. PMID: 34913089. doi:10.1007/s00134-021-06596-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。